Presidential Symposium

  • William G. Kaelin, Jr. Dana-Farber Cancer Institute USA CV

Plenary Lecture

  • Andrew TUTT The Institute of Cancer Research UK CV
  • Hans WILDIERS University Hospitals Leuven Belgium CV
  • Heather WAKELEE Stanford University USA CV

Special Symposium

  • Alex A. ADJEI Mayo Clinic USA CV
  • Jeong Ho LEE KAIST Korea CV

Scientific Symposium

Scientific Symposium 1: Current status of precision medicine in oncology area

  • Myung-Ju AHN Samsung Medical Center Korea CV
  • Emmanuel S. ANTONARAKIS The Johns Hopkins University USA CV
  • Jeeyun LEE Samsung Medical Center Korea CV

Scientific Symposium 2: IT biotech & digital health in oncology

  • Yoon Sup CHOI DHP Korea CV
  • Kyu-Hwan JUNG Vuno Korea CV
  • Changwon KEUM 3 Billion Korea CV
  • Seong Eui HONG Theragen Korea CV

Scientific Symposium 3: Emerging strategies in immunotherapy

  • Aung NAING MD Anderson Cancer Center USA CV
  • Cathy PIETANZA MSD USA CV
  • Edmund K MOON Hospital of the University of Pennsylvania USA CV

Scientific Symposium 4: State of the art on systemic therapy in HCC

  • Changhoon YOO Asan Medical Center Korea CV
  • Hong Jae CHON CHA Bundang Medical Center Korea CV
  • Stephen L. CHAN The Chinese University of Hong Kong Hong Kong CV

Scientific Symposium 5: Modulating microenvironment for cancer treatment

  • Chan KIM CHA Bundang Medical Center Korea CV
  • Sandra RYEOM UPENN USACV
  • Julia OH The Jackson Laboratory USA CV

Scientific Symposium 6: Translational Research - Biomarker studies to achieve desired clinical applications

  • Richard FINN UCLA USA CV
  • Qiang PAN-HAMMARSTROM Karolinska Institutet Sweden CV
  • Patrick TAN Duke-NUS Medical School Singapore CV

Scientific Symposium 7: GY cancer multimodality treatment

  • Keun Ho LEE The Catholic University of Korea Korea CV
  • Gun Min KIM Yonsei Cancer Center Korea CV
  • Jung-Min LEE National Cancer Institute USA CV
  • Elise C. KOHN National Cancer Institute USA CV

Scientific Symposium 8: Partnering between biotechs and investigators in early phase drug development

  • James Jungkue LEE Bridge Biotherapeutics, Inc. Korea CV
  • Jin-San YOO PharmAbcine Korea CV
  • Hansoo PARK Genome & Company Korea CV
  • Hyunjung Helen LEE Samyang Biopharm USA USA CV

Scientific Symposium 9: Understanding and targeting the epigenome in liver cancer

  • Keith D. ROBERTSON Mayo Clinic USA CV
  • Young-Joon KIM Yonsei University Korea CV
  • Young Hyeh KO Samsung Medical Center Korea CV

Scientific Symposium 10: Geriatric Oncology

  • Kwang Il KIM Seoul National University Hospital Korea CV
  • Jee Hyun KIM Seoul National University Hospital Korea CV
  • Ravindran KANESVARAN National Cancer Centre Singapore Singapore CV
  • Hans WILDIERS University Hospitals Leuven Belgium CV

Scientific Symposium 11: Radiomics in thoracic oncology

  • Ji Eun PARK Asan Medical Center Korea CV
  • Philipp KICKINGEREDER Heidelberg University Hospital Germany CV
  • Kyu Pyo KIM Asan Medical Center Korea CV
  • Ho Yun LEE Samsung Medical Center Korea CV

Joint Symposium

ASCO/KSMO Joint Symposium 1:Progress in precision medicine through global collaboration - I. Utilization of NGS to improve patient care

  • Edward Sanghyun KIM Levine Cancer Institute USA CV
  • Tae-You KIM Seoul National University Hospital Korea CV
  • Subha MADHAVAN Georgetown University USA CV

ASCO/KSMO Joint Symposium 2:Progress in precision medicine through global collaboration - II. Integrated platform for precision medicine

  • TBD TBD TBD CV
  • Woong Yang PARK Samsung Medical Center Korea CV
  • Jee Hyun KIM Seoul National University Bundang Hospital Korea CV

KOSRO/KSMO Joint Symposium: The promise of combining RT and Immunotherapy

  • David RABEN University of Colorado USA CV
  • Jin Ho KIM Seoul National University Hospital Korea CV
  • Keun-Wook LEE Seoul National University Bundang Hospital Korea CV

KCSG/KSMO Joint Symposium: Multidisciplinary Efforts for Awareness and Minimizing Toxicities from Systemic Cancer Therapy

  • Tae Jung OH Seoul National University Bundang Hospital Korea CV
  • TBD TBD TBD CV
  • Eric LANCASTER UPENN USA CV
  • Jin-Hyoung KANG Seoul St. Mary’s Hospital Korea CV

JSMO/KSMO Joint Symposium: Clinical Trials in Asia: Opportunities and Challenges

  • Takayuki Yoshino National Cancer Center Hospital East Japan CV
  • Toshio Shimizu National Cancer Center Hospital Japan Japan CV
  • Do-Youn OH Seoul National University Hospital Korea CV
  • Sun Young RHA Yonsei Cancer Center Korea CV

KSSO/KSMO Joint Symposium: Evolving strategies for surgery and systemic therapy in the neoadjuvant treatment era

  • Paul F. MANSFIELD MD Anderson Cancer Center USA CV
  • Masanori TERASHIMA Shizuoka Cancer Center Japan CV
  • Eun-Kee SONG Chonbuk National University Hospital Korea CV

KSP/KSMO Joint Symposium: Immune Biomarker

  • Patricia MARINELLO MSD USA CV
  • Tae-Jung KIM Yeouido St. Mary's Hospital Korea CV
  • Hee Jin LEE Asan Medical Center Korea CV

Education Session

Multidisciplinary Oncology Team Education Session 1: Immuno-oncologic Therapy and Pharmacologic Management

  • Jung Ae Seo National Cancer Center Korea CV
  • Juhyang Cheon Yeungnam University Hospital Korea CV
  • Soyeon Hong Seoul National University Bundang Hospital Korea CV

Multidisciplinary Oncology Team Education Session 2: Oncology nursing care in immune-oncology and targeted agent

  • Moon Ki CHOI National Cancer Center Korea CV
  • Eun Joo KANG Korea University Guro Hospital Korea CV
  • Jae Ho JEONG Asan Medical Center Korea CV
  • Yun-Gyoo LEE Kangbuk Samsung Hospital Korea CV

Multidisciplinary Oncology Team Education Session 3: CRC/CRA in clinical trial of precision medicine

  • Jeong Eun KIM Asan Medical Center Korea CV
  • Min Hwan KIM Yonsei Cancer Center Korea CV
  • Hee Kyung AHN Gachon University Gil Medical Center Korea CV

KCCA Symposium